Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 732, pseudogene (RN7SL732P)

Target
RN7SL732P
Molecular classification
Pseudogene, Non-coding RNA, Processed pseudogene (derived from reverse-transcription and integration of the parental RNA), Not a protein-coding gene
01

Overview

The RNA, 7SL, cytoplasmic 732, pseudogene (RN7SL732P) is a genomic locus classified as a transcribed pseudogene derived from the 7SL RNA, which canonically forms the RNA backbone for the signal recognition particle (SRP) complex involved in cotranslational targeting of proteins to the endoplasmic reticulum[5][1]. Hundreds of such pseudogenes exist in the human genome, arising by reverse transcription and reintegration of 7SL RNA or its truncations, with considerable structural diversity and little, if any, protein-coding capacity[7]. While the parental 7SL RNA sequence is critical for protein sorting and translation regulation, its pseudogenes—such as RN7SL732P—have unclear biological roles, though some pseudogenes may participate in regulatory RNA networks or serve as sources of small siRNAs or epigenetic modulators[4]. There is no evidence that RN7SL732P plays a role in disease, interacts with drugs, or is used as a biomarker, and it is not referenced as a canonical therapeutic target.

Other names
RN7SL732PRNA, 7SL, cytoplasmic 732, pseudogene7SL RNA pseudogene (generic, not specific to this locus)
02

Mechanism of action

None established.

03

Biological functions

Unclear for this specific locus.Some pseudogenes (including 7SL derivatives) may act as competitive endogenous RNAs (ceRNAs), serving as miRNA decoys to regulate parental gene expression or produce small regulatory RNAs.Canonical 7SL RNA is central in SRP-mediated protein targeting and translational regulation, but pseudogenes typically lack these functions.
04

Disease associations

No known direct association for RN7SL732P.Some pseudogenes have roles in cancer or serve as regulatory RNAs, but direct evidence for RN7SL732P is lacking.
05

Safety considerations

None known. As an inactive pseudogene, there are no safety or therapeutic risks.
06

Interacting drugs

None reported.
07

Biomarkers

None reported. Pseudogenes are occasionally used in transcriptomic profiling, but RN7SL732P is not a known biomarker.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 732, pseudogene (RN7SL732P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 732, pseudogene (RN7SL732P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call